Area: Internal Medicine
Location: Online, Virtual
Date: October 27 to October 28
Antiphospholipid Antibodies Increase Risk of Cardiovascular Disease in Patients With Lupus
The cardiovascular effects of novel weight loss therapies
AI Technology Improves Detection of Heart Disease During, After Pregnancy
Semaglutide Reduces Cardiovascular Event Risk by 20% in Overweight, Obese People Without Diabetes
Abelacimab Superior to Rivaroxaban in Reducing Bleeding in Patients With Atrial Fibrillation
Association of depression trajectories and subsequent hypertension and cardiovascular disease: findings from the CHARLS cohort
Is There an Association Between Atrial Fibrillation Onset Age and Incident Dementia?
CT attenuation correction improves quantitative risk prediction by cardiac SPECT in obese patients
Sotagliflozin Protects Renal and Heart Health in Patients With Type 2 Diabetes, CKD
First Classification of 4 Stages of MI Based on Heart Muscle Damage Is Released
Nirmatrelvir-ritonavir tied to lower risk of adverse pregnancy outcomes following COVID-19
The current best drug treatment for hypertensive heart failure with preserved ejection fraction
Nirmatrelvir-ritonavir does not reduce risk of most post-COVID-19 conditions
Surgery, TAVR Provide Similar 5-Year Outcomes in Low-Risk Patients With Severe Aortic Stenosis
Dexmedetomidine Withdrawal Syndrome in Children in the PICU: Systematic Review and Meta-Analysis
Empagliflozin shows no clinical benefit in patients hospitalised with COVID-19